IMNM vs MSFT: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Microsoft Corp in 2026
IMNM
Immunome Inc
$22.61
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | IMNM | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.45B | N/A | IMNM |
| P/E Ratio | N/A | 24.04 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | -1.0% | 0.2% | MSFT |
| Gross Margin | -2454.2% | 68.6% | MSFT |
Analyze IMNM
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or MSFT a better investment?
Comparing IMNM and MSFT: Immunome Inc has a market cap of $2.45B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and MSFT?
IMNM (Immunome Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or MSFT?
MSFT has higher revenue growth at 0.2% vs -1.0% for IMNM.
Which company is more profitable: IMNM or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -2454.2% for IMNM.
Which is the larger company: IMNM or MSFT?
Immunome Inc (IMNM) is larger with a market cap of $2.45B compared to N/A for MSFT.
Should I buy IMNM or MSFT in 2026?
Both IMNM and MSFT have investment merit. IMNM trades at $22.61 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and MSFT stock?
Key differences: Market Cap ($2.45B vs N/A), P/E Ratio (N/A vs 24.0x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (-2454.2% vs 68.6%).